AIM
TCRT icon

Axiom Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Axiom Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104 Buy
+46
New +$118 ﹤0.01% 507

Other funds holding TCRT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
KFI
Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

Axiom Investment Management's TCRT Position: Q2 2026 in Review

Axiom Investment Management opened a new position in Alaunos Therapeutics (TCRT) in Q2 2026: 46 shares worth $104. The stake represents ﹤0.01% of the portfolio and ranks #507 among its holdings.

7 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.

  • Axiom Investment Management held 46 shares of Alaunos Therapeutics worth $104 as of Q2 2026.
  • Alaunos Therapeutics was a new Axiom Investment Management position in Q2 2026.
  • Alaunos Therapeutics made up ﹤0.01% of Axiom Investment Management's portfolio in Q2 2026, its #507 holding.
  • 7 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.